Evidence map›Paper›PMID 28503138›Full record

ArticleFrontiers in human neuroscience2017

Enhanced Feedback-Related Negativity in Alzheimer's Disease.

Eri Nitta, Keiichi Onoda, Fuminori Ishitobi, Ryota Okazaki, Seiji Mishima, Atsushi Nagai, Shuhei Yamaguchi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in human neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eri NittaCentral Clinical Laboratory, Shimane University HospitalIzumo, Japan.
Keiichi OnodaDepartment of Neurology, Shimane University Faculty of MedicineIzumo, Japan.
Fuminori IshitobiCentral Clinical Laboratory, Shimane University HospitalIzumo, Japan.
Ryota OkazakiCentral Clinical Laboratory, Shimane University HospitalIzumo, Japan.
Seiji MishimaCentral Clinical Laboratory, Shimane University HospitalIzumo, Japan.
Atsushi NagaiCentral Clinical Laboratory, Shimane University HospitalIzumo, Japan.
Shuhei YamaguchiDepartment of Neurology, Shimane University Faculty of MedicineIzumo, Japan.
Shimane University Hospital · JPShimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD), the most common cause of dementia in the elderly, results in the impairment of executive function, including that of performance monitoring. Feedback-related negativity (FRN) is an electrophysiological measure reflecting the activity of this monitoring system via feedback signals, and is generated from the anterior cingulate cortex. However, there have been no reports on FRN in AD. Based on prior aging studies, we hypothesized that FRN would decrease in AD patients. To assess this, FRN was measured in healthy individuals and those with AD during a simple gambling task involving positive and negative feedback stimuli. Contrary to our hypothesis, FRN amplitude increased in AD patients, compared with the healthy elderly. We speculate that this may reflect the existence of a compensatory mechanism against the decline in executive function. Also, there was a significant association between FRN amplitude and depression scores in AD, and the FRN amplitude tended to increase insomuch as the Self-rating Depression Scale (SDS) was higher. This result suggests the existence of a negative bias in the affective state in AD. Thus, the impaired functioning monitoring system in AD is a more complex phenomenon than we thought.

Indexed as

agingAlzheimer’s diseasedepressionfeedback-related negativitymonitoring systems

Identifiers

PMID28503138
PMCPMC5408015
OpenAlexW2609028795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.